CRISPR-Cas9

three spotlights on a stage
Biotech

It's curtain close for Spotlight: Gene editing biotech shutters

Spotlight had launched in 2020 with money from Alphabet’s venture capital arm GV (Google Ventures).
Gabrielle Masson Feb 19, 2025 4:28pm
gene edits scientists gene editing CRISPR

Editas cashes in on Vertex Cas9 licensing agreement for $57M

Oct 4, 2024 5:06am
gene editing edit gene CRISPR

CRISPR gene therapy for deafness works in young adult mice

Jul 11, 2024 9:15am
start race starting block runners go advance

Intellia showcases durability of one-and-done HAE option

Jun 2, 2024 8:00am
Graphic of a fork in the road with arrows pointing in either direction

Intellia opts out of hemophilia gene editing work with Regeneron

Mar 22, 2024 11:21am
gene edits scientists gene editing CRISPR

Vertex pays Editas $100M to use gene-editing tech

Dec 13, 2023 12:46pm